The activated ERK1/2 enters the nucleus and continuously activates Cyclin D1 and proliferating cell nuclear antigen (PCNA), disrupting the balance of cell cycle regulation and leading to abnormal proliferation of hepatoblastoma cells (Xiao et al., 2021). Here, PCNA is linked to hepatoblastoma.